Innovate UK – Biomedical Catalyst Call 2019

Take on the biggest healthcare challenges: apply for funding  

UK businesses can apply for a share of up to £10 million to develop technologies, products and processes that could offer better outcomes for patients.

The Biomedical Catalyst supports UK businesses to test and develop innovative technologies for healthcare. Through the Biomedical Catalyst – a partnership between Innovate UK and the Medical Research Council – there is up to £10 million available to UK businesses to:

  •   prevent disease and support proactive management of health conditions
  •   detect and diagnose disease earlier, leading to better patient outcomes
  •   develop tailored treatments that offer potential cures or change an underlying disease

Projects in the competition can be in any life science sector or discipline, including:

  •   medical technologies and devices
  •   stratified healthcare, which involves grouping patients based on risk of disease or response to therapy
  •   advanced therapies, such as gene and cell therapies
  •   digital health
  •   drug discovery
  •   diagnostics

There are 2 parts:

  •   feasibility studies and primer awards, for projects to test and provide proof of concept
  •   early and late stage awards for projects that are further along in their development

Feasibility and primer projects

There is up to £3 million for organisations to explore the commercial potential of an idea and carry out technical evaluations.

This could be through:

  •   reviewing research evidence and identifying possible applications
  •   assessing business opportunities
  •   assessing or protecting intellectual property
  •   validating initial concepts and pre-clinical work through experimental studies
  •   initial demonstration using in-vitro and in-vivo models, but not human clinical trials
  •   early-stage prototyping
  •   developing preliminary regulatory advice

Competition information

  •   the competition opens on 21 January 2019 and the deadline for applications is midday on 3 April 2019
  •   UK-registered small and medium-sized enterprises (SME) or research and technology organisations are eligible to lead a project
  •   total eligible costs must be between £50,000 and £1 million
  •   projects must start by 1 September 2019 and end by 31 March 2021. They should last between 3 and 18 months
  •   businesses could get up to 70% of their eligible costs

For more information and to apply, please click here

MediWales Supporters:

Subscribe to our Mediwales newsletter